Benefits of pressure-controlled hemostasis for transradial vascular access: a randomized controlled trial.

CONCLUSIONS: Compared to conventional hemostasis, pressure-controlled hemostasis with systolic blood pressure plus 20 mmHg significantly reduced pain at the hemostasis site after transradial vascular access without increasing the incidence of other complications.
PMID: 31789006 [PubMed - as supplied by publisher]

Source: Minerva Cardioangiologica - December 5, 2019 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research